SCHEMBL1481888

SCHEMBL1481888

C=C(C)C(=O)OCC1SCCCS1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
TSHR P16473 3/20 0.40
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9618171 0.93 ALDH1A1 (0.55) ALDH1A1TSHRTHRB
SCHEMBL13434034 0.81 ALDH1A1 (0.36) ALDH1A1TSHR
SCHEMBL635021 0.76 ALDH1A1 (0.56) ALDH1A1TSHRTHRB
SCHEMBL7050248 0.75 THRB (0.46) ALDH1A1TSHRTHRB
SCHEMBL4904938 0.72 ALDH1A1 (0.56) ALDH1A1TSHRTHRB
SCHEMBL11481185 0.72 ALDH1A1 (0.56) ALDH1A1TSHRTHRB
SCHEMBL16145863 0.72 ALDH1A1 (0.38) ALDH1A1TSHR
SCHEMBL15928283 0.72 ALDH1A1 (0.56) ALDH1A1TSHRTHRB
SCHEMBL6862999 0.71 ALDH1A1 (0.47) ALDH1A1TSHRTHRB
SCHEMBL496421 0.71 ALDH1A1 (0.60) ALDH1A1TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349536-B2 Dithiane derivative, polymer, resist composition, and method for manufacturing semiconductor device using such resist composition FUJITSU LIMITED (JP) 2013-01-08 US disclosed
US-8349536-B2 Dithiane derivative, polymer, resist composition, and method for manufacturing semiconductor device using such resist composition FUJITSU LIMITED (JP) 2013-01-08 US disclosed
US-8349536-B2 Dithiane derivative, polymer, resist composition, and method for manufacturing semiconductor device using such resist composition FUJITSU LIMITED (JP) 2013-01-08 US disclosed
US-20110076620-A1 DITHIANE DERIVATIVE, POLYMER, RESIST COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING SUCH RESIST COMPOSITION FUJITSU LIMITED (JP) 2011-03-31 US disclosed
US-20110076620-A1 DITHIANE DERIVATIVE, POLYMER, RESIST COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING SUCH RESIST COMPOSITION FUJITSU LIMITED (JP) 2011-03-31 US disclosed
US-20110076620-A1 DITHIANE DERIVATIVE, POLYMER, RESIST COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING SUCH RESIST COMPOSITION FUJITSU LIMITED (JP) 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076620-A1 DITHIANE DERIVATIVE, POLYMER, RESIST COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING SUCH RESIST COMPOSITION DDAH1, TMT1A, TST ALDH1A1 1400/4885TSHR 1308/4885THRB 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.